“…In this issue of Journal of Nuclear Cardiology, Frey et al retrospectively enrolled a very large-scale population of 2496 patients to study the stress-induced effects of two vasodilator agents (adenosine and regadenoson) by ECG-gated myocardial perfusion imaging (MPI) with Rb-82 PET/CT on functional variables including stress left ventricular ejection fraction (LVEF), rest LVEF, LVEF reserve, stress myocardial blood flow (MBF), rest MBF, MBF reserve and hemodynamic variables in patients with or without prior history of coronary artery disease (CAD) and normal or abnormal scan results (summed stress score [SSS] \ 4 or SSS C 4). 1 Although similar studies on comparing different vasodilator agents had been reported, this study was likely the largest single center study of Rb-82 PET data. The main findings concluded by the authors were: (1) The clinical significance of non-perfusion variables obtained from vasodilator-stress gated MPI with SPECT or PET, such as LVEF, LVEF reserve, wall motion, transient LV ischemic dilation (TID), and dyssynchrony had been widely studied and shown to have incremental values on the diagnosis and risk stratification of patients with ischemic heart disease.…”